135 related articles for article (PubMed ID: 38215238)
1. Surgery for oligometastatic pancreatic cancer: next frontier?
Larsson P; Søreide K
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38215238
[No Abstract] [Full Text] [Related]
2. The surgical challenge of oligometastatic pancreatic cancer: A systemic review of the literature.
Christodoulidis G; Magouliotis E; Samara AA; Floros T; Zotos PA; Tolia M; Zacharoulis D
J BUON; 2021; 26(5):1742-1746. PubMed ID: 34761577
[TBL] [Abstract][Full Text] [Related]
3. Searching for novel multimodal treatments in oligometastatic pancreatic cancer.
Filippini DM; Grassi E; Palloni A; Carloni R; Casadei R; Ricci C; Serra C; Ercolani G; Brandi G; Di Marco M
BMC Cancer; 2020 Mar; 20(1):271. PubMed ID: 32228504
[TBL] [Abstract][Full Text] [Related]
4. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
[TBL] [Abstract][Full Text] [Related]
5. [There is a role for surgical resection in patients with oligometastatic pancreatic cancer].
Targarona Modena J; Coayla Castillo G; Hurtado de Mendoza F; Bisso Andrade A; Balarezo Aguilar S
Rev Gastroenterol Peru; 2021; 41(4):233-238. PubMed ID: 35613393
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous resection of oligometastatic pancreatic cancer: The 5-Year follow-up in a single center.
Wu Z; Chen L; Tian B
Asian J Surg; 2023 Jan; 46(1):657-658. PubMed ID: 35850905
[No Abstract] [Full Text] [Related]
7. Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question.
Scorsetti M; Comito T; Franceschini D; Franzese C; Prete MG; D'Alessio A; Bozzarelli S; Rimassa L; Santoro A
Br J Radiol; 2020 Feb; 93(1106):20190627. PubMed ID: 31825664
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate.
van Vliet EI; van Eijck CH; de Krijger RR; Nieveen van Dijkum EJ; Teunissen JJ; Kam BL; de Herder WW; Feelders RA; Bonsing BA; Brabander T; Krenning EP; Kwekkeboom DJ
J Nucl Med; 2015 Nov; 56(11):1647-53. PubMed ID: 26272813
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection of pancreatic cancer with synchronous hepatic oligometastases: Real benefit or selection bias?
Ansari D; Andersson R
Scand J Surg; 2022; 111(2):14574969221096513. PubMed ID: 35695273
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
[TBL] [Abstract][Full Text] [Related]
11. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
[TBL] [Abstract][Full Text] [Related]
12. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis.
Feng Q; Li C; Zhang S; Tan CL; Mai G; Liu XB; Chen YH
World J Gastroenterol; 2019 Oct; 25(39):6006-6015. PubMed ID: 31660036
[TBL] [Abstract][Full Text] [Related]
13. Recent Developments in the Treatment of Pancreatic Cancer.
Paulino J; Mansinho H
Acta Med Port; 2023 Oct; 36(10):670-678. PubMed ID: 37788655
[TBL] [Abstract][Full Text] [Related]
14. Radical surgery of oligometastatic pancreatic cancer.
Hackert T; Niesen W; Hinz U; Tjaden C; Strobel O; Ulrich A; Michalski CW; Büchler MW
Eur J Surg Oncol; 2017 Feb; 43(2):358-363. PubMed ID: 27856064
[TBL] [Abstract][Full Text] [Related]
15. Management problems in patients with pancreatic cancer from a surgeon's perspective.
Klose J; Ronellenfitsch U; Kleeff J
Semin Oncol; 2021 Feb; 48(1):76-83. PubMed ID: 34059343
[TBL] [Abstract][Full Text] [Related]
16. Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer.
Chang SC; Hsu CP; Tsai CY; Liu YY; Liu KH; Hsu JT; Yeh TS; Yeh CN; Hwang TL
Medicine (Baltimore); 2016 Jul; 95(30):e4191. PubMed ID: 27472688
[TBL] [Abstract][Full Text] [Related]
17. Current status of pancreatic cancer with oligometastasis.
Chapa-Azuela Ó; Corona-Torres MJ; Ayala-Moreno EA; Arroyo-Paredes PS; Pérez-Torres E; Rodríguez-Báez A; Montalvo-Javé EE
Cir Cir; 2023; 91(2):262-267. PubMed ID: 37084317
[TBL] [Abstract][Full Text] [Related]
18. [A.A. Shalimov and modern approaches to the surgical treatment of cancer of the pancreatic head and periampullar zone organs].
Kopchak VM; Usenko AIu; Chornyĭ VV; Khomiak IV; Kopchak KV; Duvalko AV
Klin Khir; 2007; (2-3):26-9. PubMed ID: 17515063
[No Abstract] [Full Text] [Related]
19. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
[TBL] [Abstract][Full Text] [Related]
20. [Indications for Surgery in Pancreatic Ductal Adenocarcinoma - Consensus Recommendations by the German Society for General and Visceral Surgery].
Belyaev O; Bösch F; Brunner M; Müller-Debus CF; Radulova-Mauersberger O; Wellner UF; Grützmann R; Keck T; Werner J; Witzigmann H; Uhl W
Zentralbl Chir; 2020 Aug; 145(4):354-364. PubMed ID: 32615624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
